rss
Gut 2005;54:54-59 doi:10.1136/gut.2003.032094
  • Coeliac disease

Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma

  1. K E Smedby1,
  2. M Åkerman2,
  3. H Hildebrand3,
  4. B Glimelius4,
  5. A Ekbom5,
  6. J Askling6
  1. 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  2. 2Department of Pathology, Lund University Hospital, Lund, Sweden
  3. 3Department of Paediatrics, Astrid Lindgrens Children’s Hospital, Stockholm, Sweden
  4. 4Department of Oncology, Radiology, and Clinical Immunology, Uppsala University Hospital and Department of Oncology and Pathology, Karolinska Hospital, Stockholm, Sweden
  5. 5Department of Medicine, Clinical Epidemiology Unit, Karolinska Hospital, Stockholm, Sweden
  6. 6Department of Medicine, Clinical Epidemiology Unit, and Department of Medicine, Rheumatology Unit, Karolinska Hospital, Stockholm, Sweden
  1. Correspondence to:
    Dr K E Smedby
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE-171 77 Stockholm, Sweden; karin.ekstrommeb.ki.se
  • Accepted 25 April 2004
  • Revised 14 April 2004

Abstract

Background: Numerous studies have reported on the association between coeliac disease and the otherwise uncommon enteropathy-type T cell lymphoma (ETTL). A systematic risk assessment of more prevalent lymphoma entities, such as B cell and non-intestinal lymphomas, in coeliac disease has not been performed.

Aims: In light of the increasing number of patients diagnosed with coeliac disease and the unknown aetiology of malignant lymphomas, we aimed to estimate the distribution and risk of lymphoma subtypes in coeliac disease.

Methods: We reviewed and reclassified 56 cases of incident malignant lymphomas occurring in a Swedish population based cohort of 11 650 patients hospitalised with coeliac disease. The observed numbers of lymphoma subtypes were compared with those expected in the Swedish population.

Results: The majority (n = 32, 57%) of lymphomas in the cohort were not intestinal T cell lymphomas. Significantly increased risks were observed for B cell non-Hodgkin lymphoma (NHL) (standardised incidence ratio (SIR) 2.2 (95% confidence interval (CI) 1.2–3.6); 11 non-intestinal and five intestinal) and for lymphomas of non-intestinal origin (SIR 3.6 (95% CI 2.3–5.2), 11 B and 14 T cell). Furthermore, 44% of patients with B cell NHL had a history of other autoimmune/inflammatory diseases. The relative risks for T cell NHL (SIR 51 (95% CI 35–68); n = 37) and for primary gastrointestinal lymphomas (SIR 24 (95% CI 16–34); five B and 25 T cell) were markedly increased, as anticipated.

Conclusion: Most lymphomas complicating coeliac disease are indeed related to the disease and are not of the ETTL-type. There was a remarkable aggregation of autoimmune/inflammatory disorders, female sex, coeliac disease, and B cell lymphoma.

Footnotes

  • Conflict of interest: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.